http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5276601

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 421
issn 2324-9269
issueIdentifier 5
pageRange 412-421
publicationName Molecular Genetics & Genomic Medicine
startingPage 412
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dfa1760c2c74ba452bfd8f8333c92eb1
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eebe3754fdacac69eb7a7bff07fa0833
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d39c7659059af6db77ac866ec3530178
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e04cc10b9ddb6afcc4c6b032be203f4e
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5e37fdd43eb04fb0446eebb0485bab9
bibliographicCitation Trujillano D, Bullich G, Ossowski S, Ballarín J, Torra R, Estivill X, Ars E. Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next‐generation sequencing. Mol Genet Genomic Med. 2014 May 23;2(5):412–21. doi: 10.1002/mgg3.82.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_225a98800789aa9cca65abd901896c0a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb41d97dad5648f18f5bfc65ed92e5b3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a39a4ba5d17e59910fd51012bf4a6c23
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4118-4358
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_603ee1025ef6d5c849e36146c5d66e38
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_736d12af3d6bd9307b5e47c43ddde542
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b716d2338c1c9a0ca25515d476dd189
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3352dbcced272466e094465ae84cb8cf
date 2014-05-23^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1002/mgg3.82
https://pubmed.ncbi.nlm.nih.gov/25333066
https://pubmed.ncbi.nlm.nih.gov/PMC4190876
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/41103
https://portal.issn.org/resource/ISSN/2324-9269
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next‐generation sequencing
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_049883b65ce87a12bb1c8e7bc6ebd2ec
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdaebc88bfbee183eaf74a8ece5922be
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9952
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8937

Showing number of triples: 1 to 35 of 35.